{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,24]],"date-time":"2026-01-24T08:29:49Z","timestamp":1769243389385,"version":"3.49.0"},"reference-count":76,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2011,7,1]],"date-time":"2011-07-01T00:00:00Z","timestamp":1309478400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2011,7,1]],"date-time":"2011-07-01T00:00:00Z","timestamp":1309478400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Seminars in Hematology"],"published-print":{"date-parts":[[2011,7]]},"DOI":"10.1053\/j.seminhematol.2011.04.001","type":"journal-article","created":{"date-parts":[[2011,7,25]],"date-time":"2011-07-25T03:35:06Z","timestamp":1311564906000},"page":"155-165","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":15,"title":["Molecular Pathogenesis of Mantle Cell Lymphoma: New Perspectives and Challenges With Clinical Implications"],"prefix":"10.1053","volume":"48","author":[{"given":"Alba","family":"Navarro","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cristina","family":"Royo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Luis","family":"Hern\u00e1ndez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pedro","family":"Jares","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"El\u00edas","family":"Campo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1053\/j.seminhematol.2011.04.001_bib1","doi-asserted-by":"crossref","first-page":"750","DOI":"10.1038\/nrc2230","article-title":"Genetic and molecular pathogenesis of mantle cell lymphoma: perspectives for new targeted therapeutics","volume":"7","author":"Jares","year":"2007","journal-title":"Nat Rev Cancer"},{"key":"10.1053\/j.seminhematol.2011.04.001_bib2","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1111\/j.1365-2141.2008.07124.x","article-title":"Advances in the understanding of mantle cell lymphoma","volume":"142","author":"Jares","year":"2008","journal-title":"Br J Haematol"},{"key":"10.1053\/j.seminhematol.2011.04.001_bib3","first-page":"1629","article-title":"Templated nucleotide addition and immunoglobulin JH-gene utilization in t(11;14) junctions: implications for the mechanism of translocation and the origin of mantle cell lymphoma","volume":"61","author":"Welzel","year":"2001","journal-title":"Cancer Res"},{"key":"10.1053\/j.seminhematol.2011.04.001_bib4","doi-asserted-by":"crossref","first-page":"3003","DOI":"10.1182\/blood-2003-05-1383","article-title":"VH mutation status and VDJ rearrangement structure in mantle cell lymphoma: correlation with genomic aberrations, clinical characteristics, and outcome","volume":"102","author":"Kienle","year":"2003","journal-title":"Blood"},{"key":"10.1053\/j.seminhematol.2011.04.001_bib5","article-title":"Sequence-based evidence for antigen selection in mantle cell lymphoma: remarkable immunoglobulin gene repertoire biases, stereotyped antigen-binding sites and recurrent hypermutations in certain subsets","author":"Hadzidimitriou","year":"2009","journal-title":"51st American Society of Hematology Annual Meeting, New Orleans, LA"},{"key":"10.1053\/j.seminhematol.2011.04.001_bib6","doi-asserted-by":"crossref","first-page":"4975","DOI":"10.1182\/blood-2002-06-1864","article-title":"A subset of t(11;14) lymphoma with mantle cell features displays mutated IgVH genes and includes patients with good prognosis, nonnodal disease","volume":"101","author":"Orchard","year":"2003","journal-title":"Blood"},{"key":"10.1053\/j.seminhematol.2011.04.001_bib7","doi-asserted-by":"crossref","first-page":"4042","DOI":"10.1182\/blood-2002-11-3456","article-title":"Molecular heterogeneity in MCL defined by the use of specific VH genes and the frequency of somatic mutations","volume":"101","author":"Camacho","year":"2003","journal-title":"Blood"},{"key":"10.1053\/j.seminhematol.2011.04.001_bib8","doi-asserted-by":"crossref","first-page":"2545","DOI":"10.1182\/blood-2006-07-037150","article-title":"A novel human B cell subpopulation representing the initial germinal center population to express AID","volume":"109","author":"Kolar","year":"2007","journal-title":"Blood"},{"key":"10.1053\/j.seminhematol.2011.04.001_bib9","doi-asserted-by":"crossref","first-page":"822","DOI":"10.1182\/blood-2008-03-142182","article-title":"Truncation in CCND1 mRNA alters miR-16-1 regulation in mantle cell lymphoma","volume":"112","author":"Chen","year":"2008","journal-title":"Blood"},{"key":"10.1053\/j.seminhematol.2011.04.001_bib10","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1186\/1471-2407-9-194","article-title":"Systematic validation of predicted microRNAs for cyclin D1","volume":"9","author":"Jiang","year":"2009","journal-title":"BMC Cancer"},{"key":"10.1053\/j.seminhematol.2011.04.001_bib11","doi-asserted-by":"crossref","first-page":"4599","DOI":"10.1182\/blood-2006-08-039859","article-title":"Point mutations and genomic deletions in CCND1 create stable truncated cyclin D1 mRNAs that are associated with increased proliferation rate and shorter survival","volume":"109","author":"Wiestner","year":"2007","journal-title":"Blood"},{"key":"10.1053\/j.seminhematol.2011.04.001_bib12","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1002\/ijc.21166","article-title":"Mantle cell lymphomas with low levels of cyclin D1 long mRNA transcripts are highly proliferative and can be discriminated by elevated cyclin A2 and cyclin B1","volume":"117","author":"Sander","year":"2005","journal-title":"Int J Cancer"},{"key":"10.1053\/j.seminhematol.2011.04.001_bib13","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1016\/S1535-6108(03)00028-X","article-title":"The proliferation gene expression signature is a quantitative integrator of oncogenic events that predicts survival in mantle cell lymphoma","volume":"3","author":"Rosenwald","year":"2003","journal-title":"Cancer Cell"},{"key":"10.1053\/j.seminhematol.2011.04.001_bib14","first-page":"1005","article-title":"Alternate splicing produces a novel cyclin D1 transcript","volume":"11","author":"Betticher","year":"1995","journal-title":"Oncogene"},{"key":"10.1053\/j.seminhematol.2011.04.001_bib15","doi-asserted-by":"crossref","first-page":"1744","DOI":"10.1182\/blood-2006-04-016634","article-title":"Mantle cell lymphoma cells express predominantly cyclin D1a isoform and are highly sensitive to selective inhibition of CDK4 kinase activity","volume":"108","author":"Marzec","year":"2006","journal-title":"Blood"},{"key":"10.1053\/j.seminhematol.2011.04.001_bib16","doi-asserted-by":"crossref","first-page":"2097","DOI":"10.1038\/leu.2008.213","article-title":"Specific lentiviral shRNA-mediated knockdown of cyclin D1 in mantle cell lymphoma has minimal effects on cell survival and reveals a regulatory circuit with cyclin D2","volume":"22","author":"Klier","year":"2008","journal-title":"Leukemia"},{"key":"10.1053\/j.seminhematol.2011.04.001_bib17","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1016\/j.ccr.2010.08.012","article-title":"Nuclear cyclin D1\/CDK4 kinase regulates CUL4 expression and triggers neoplastic growth via activation of the PRMT5 methyltransferase","volume":"18","author":"Aggarwal","year":"2010","journal-title":"Cancer Cell"},{"key":"10.1053\/j.seminhematol.2011.04.001_bib18","doi-asserted-by":"crossref","first-page":"8802","DOI":"10.1158\/0008-5472.CAN-10-0312","article-title":"Alternative cyclin D1 splice forms differentially regulated DNA damage response","volume":"70","author":"Li","year":"2010","journal-title":"Cancer Res"},{"key":"10.1053\/j.seminhematol.2011.04.001_bib19","doi-asserted-by":"crossref","first-page":"1595","DOI":"10.3324\/haematol.2009.010173","article-title":"Differential diagnosis of cyclin D2+ mantle cell lymphoma based on fluorescence in situ hybridization and quantitative real-time-PCR","volume":"94","author":"Quintanilla-Martinez","year":"2009","journal-title":"Haematologica"},{"key":"10.1053\/j.seminhematol.2011.04.001_bib20","doi-asserted-by":"crossref","first-page":"1216","DOI":"10.1200\/JCO.2006.08.4251","article-title":"Specific secondary genetic alterations in mantle cell lymphoma provide prognostic information independent of the gene expression-based proliferation signature","volume":"25","author":"Salaverria","year":"2007","journal-title":"J Clin Oncol"},{"key":"10.1053\/j.seminhematol.2011.04.001_bib21","doi-asserted-by":"crossref","first-page":"1109","DOI":"10.1182\/blood-2006-01-0015","article-title":"A chromosomal translocation in cyclin D1-negative\/cyclin D2-positive mantle cell lymphoma fuses the CCND2 gene to the IGK locus","volume":"108","author":"Gesk","year":"2006","journal-title":"Blood"},{"key":"10.1053\/j.seminhematol.2011.04.001_bib22","doi-asserted-by":"crossref","first-page":"5683","DOI":"10.1182\/blood-2007-10-118794","article-title":"Translocations targeting CCND2, CCND3, and MYCN do occur in t(11;14)-negative mantle cell lymphomas","volume":"111","author":"Wlodarska","year":"2008","journal-title":"Blood"},{"key":"10.1053\/j.seminhematol.2011.04.001_bib23","doi-asserted-by":"crossref","first-page":"1745","DOI":"10.1182\/blood-2007-10-120824","article-title":"Cyclin D1-negative mantle cell lymphoma with cryptic t(12;14)(p13;q32) and cyclin D2 overexpression","volume":"111","author":"Herens","year":"2008","journal-title":"Blood"},{"key":"10.1053\/j.seminhematol.2011.04.001_bib24","doi-asserted-by":"crossref","first-page":"1555","DOI":"10.3324\/haematol.2009.010264","article-title":"SOX11 expression is highly specific for mantle cell lymphoma and identifies the cyclin D1-negative subtype","volume":"94","author":"Mozos","year":"2009","journal-title":"Haematologica"},{"key":"10.1053\/j.seminhematol.2011.04.001_bib25","doi-asserted-by":"crossref","first-page":"800","DOI":"10.1182\/blood-2007-06-093401","article-title":"Nuclear expression of the non B-cell lineage Sox11 transcription factor identifies mantle cell lymphoma","volume":"111","author":"Ek","year":"2008","journal-title":"Blood"},{"key":"10.1053\/j.seminhematol.2011.04.001_bib26","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1111\/j.1365-2141.2008.07329.x","article-title":"The subcellular Sox11 distribution pattern identifies subsets of mantle cell lymphoma: correlation to overall survival","volume":"143","author":"Wang","year":"2008","journal-title":"Br J Haematol"},{"key":"10.1053\/j.seminhematol.2011.04.001_bib27","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1038\/modpathol.2009.140","article-title":"Nuclear expression of sox11 is highly associated with mantle cell lymphoma but is independent of t(11;14)(q13;q32) in non-mantle cell B-cell neoplasms","volume":"23","author":"Chen","year":"2010","journal-title":"Mod Pathol"},{"key":"10.1053\/j.seminhematol.2011.04.001_bib28","doi-asserted-by":"crossref","first-page":"1190","DOI":"10.1038\/leu.2009.31","article-title":"t(11;14)-positive clones can persist over a long period of time in the peripheral blood of healthy individuals","volume":"23","author":"Lecluse","year":"2009","journal-title":"Leukemia"},{"key":"10.1053\/j.seminhematol.2011.04.001_bib29","doi-asserted-by":"crossref","first-page":"e629","DOI":"10.1200\/JCO.2010.29.8992","article-title":"Mantle cell lymphoma 12 years after allogeneic bone marrow transplantation occurring simultaneously in recipient and donor","volume":"28","author":"Christian","year":"2010","journal-title":"J Clin Oncol"},{"key":"10.1053\/j.seminhematol.2011.04.001_bib30","article-title":"Evidence of long latency periods prior to development of mantle cell lymphoma","author":"Racke","year":"2010","journal-title":"52nd ASH Annual Meeting and Exposition. Orlando, FL"},{"key":"10.1053\/j.seminhematol.2011.04.001_bib31","doi-asserted-by":"crossref","first-page":"641","DOI":"10.3324\/haematol.13030","article-title":"Secondary genomic alterations in non-Hodgkin's lymphomas: tumor-specific profiles with impact on clinical behavior","volume":"93","author":"Bea","year":"2008","journal-title":"Haematologica"},{"key":"10.1053\/j.seminhematol.2011.04.001_bib32","first-page":"4365","article-title":"Increased number of chromosomal imbalances and high-level DNA amplifications in mantle cell lymphoma are associated with blastoid variants","volume":"93","author":"Bea","year":"1999","journal-title":"Blood"},{"key":"10.1053\/j.seminhematol.2011.04.001_bib33","doi-asserted-by":"crossref","first-page":"4445","DOI":"10.1182\/blood-2004-10-3907","article-title":"Mantle-cell lymphoma genotypes identified with CGH to BAC microarrays define a leukemic subgroup of disease and predict patient outcome","volume":"105","author":"Rubio-Moscardo","year":"2005","journal-title":"Blood"},{"key":"10.1053\/j.seminhematol.2011.04.001_bib34","doi-asserted-by":"crossref","first-page":"1086","DOI":"10.1002\/gcc.20609","article-title":"Multiple recurrent chromosomal breakpoints in mantle cell lymphoma revealed by a combination of molecular cytogenetic techniques","volume":"47","author":"Salaverria","year":"2008","journal-title":"Genes Chromosomes Cancer"},{"key":"10.1053\/j.seminhematol.2011.04.001_bib35","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1182\/blood-2003-12-4175","article-title":"Genomic DNA-chip hybridization in t(11;14)-positive mantle cell lymphomas shows a high frequency of aberrations and allows a refined characterization of consensus regions","volume":"104","author":"Kohlhammer","year":"2004","journal-title":"Blood"},{"key":"10.1053\/j.seminhematol.2011.04.001_bib36","doi-asserted-by":"crossref","first-page":"1317","DOI":"10.1182\/blood-2009-09-240440","article-title":"Deregulation of the telomerase reverse transcriptase (TERT) gene by chromosomal translocations in B-cell malignancies","volume":"116","author":"Nagel","year":"2010","journal-title":"Blood"},{"key":"10.1053\/j.seminhematol.2011.04.001_bib37","doi-asserted-by":"crossref","first-page":"1686","DOI":"10.1182\/blood-2004-07-2730","article-title":"Novel chromosomal imbalances in mantle cell lymphoma detected by genome-wide array-based comparative genomic hybridization","volume":"105","author":"Schraders","year":"2005","journal-title":"Blood"},{"key":"10.1053\/j.seminhematol.2011.04.001_bib38","doi-asserted-by":"crossref","first-page":"1348","DOI":"10.1038\/sj.onc.1208300","article-title":"Genome-wide array-based CGH for mantle cell lymphoma: identification of homozygous deletions of the proapoptotic gene BIM","volume":"24","author":"Tagawa","year":"2005","journal-title":"Oncogene"},{"key":"10.1053\/j.seminhematol.2011.04.001_bib39","doi-asserted-by":"crossref","first-page":"1219","DOI":"10.1016\/j.leukres.2006.10.022","article-title":"Detailed assessment of copy number alterations revealing homozygous deletions in 1p and 13q in mantle cell lymphoma","volume":"31","author":"Thelander","year":"2006","journal-title":"Leuk Res"},{"key":"10.1053\/j.seminhematol.2011.04.001_bib40","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1111\/j.1365-2141.2005.05883.x","article-title":"Genomic and expression profiling identifies the B-cell associated tyrosine kinase Syk as a possible therapeutic target in mantle cell lymphoma","volume":"132","author":"Rinaldi","year":"2006","journal-title":"Br J Haematol"},{"key":"10.1053\/j.seminhematol.2011.04.001_bib41","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1111\/j.1365-2141.2008.07443.x","article-title":"GeneChip analyses point to novel pathogenetic mechanisms in mantle cell lymphoma","volume":"144","author":"Vater","year":"2009","journal-title":"Br J Haematol"},{"key":"10.1053\/j.seminhematol.2011.04.001_bib42","doi-asserted-by":"crossref","first-page":"3059","DOI":"10.1182\/blood-2008-07-170183","article-title":"Uniparental disomies, homozygous deletions, amplifications, and target genes in mantle cell lymphoma revealed by integrative high-resolution whole-genome profiling","volume":"113","author":"Bea","year":"2009","journal-title":"Blood"},{"key":"10.1053\/j.seminhematol.2011.04.001_bib43","doi-asserted-by":"crossref","first-page":"937","DOI":"10.1016\/j.exphem.2009.04.012","article-title":"Identified hidden genomic changes in mantle cell lymphoma using high-resolution single nucleotide polymorphism genomic array","volume":"37","author":"Kawamata","year":"2009","journal-title":"Exp Hematol"},{"key":"10.1053\/j.seminhematol.2011.04.001_bib44","doi-asserted-by":"crossref","first-page":"953","DOI":"10.1182\/blood-2010-01-263806","article-title":"Pathway discovery in mantle cell lymphoma by integrated analysis of high-resolution gene expression and copy number profiling","volume":"116","author":"Hartmann","year":"2010","journal-title":"Blood"},{"key":"10.1053\/j.seminhematol.2011.04.001_bib45","doi-asserted-by":"crossref","first-page":"5422","DOI":"10.1182\/blood-2006-11-057208","article-title":"Inactivation of RB1 in mantle-cell lymphoma detected by nonsense-mediated mRNA decay pathway inhibition and microarray analysis","volume":"109","author":"Pinyol","year":"2007","journal-title":"Blood"},{"key":"10.1053\/j.seminhematol.2011.04.001_bib46","doi-asserted-by":"crossref","first-page":"2467","DOI":"10.1182\/blood-2008-12-194852","article-title":"TNFAIP3\/A20 functions as a novel tumor suppressor gene in several subtypes of non-Hodgkin lymphomas","volume":"114","author":"Honma","year":"2009","journal-title":"Blood"},{"key":"10.1053\/j.seminhematol.2011.04.001_bib47","doi-asserted-by":"crossref","first-page":"7071","DOI":"10.1158\/0008-5472.CAN-09-1095","article-title":"MicroRNA expression, chromosomal alterations, and immunoglobulin variable heavy chain hypermutations in mantle cell lymphomas","volume":"69","author":"Navarro","year":"2009","journal-title":"Cancer Res"},{"key":"10.1053\/j.seminhematol.2011.04.001_bib48","doi-asserted-by":"crossref","first-page":"5724","DOI":"10.1158\/1078-0432.CCR-08-3215","article-title":"Phosphatidylinositol 3'-kinase catalytic subunit alpha gene amplification contributes to the pathogenesis of mantle cell lymphoma","volume":"15","author":"Psyrri","year":"2009","journal-title":"Clin Cancer Res"},{"key":"10.1053\/j.seminhematol.2011.04.001_bib49","doi-asserted-by":"crossref","first-page":"847","DOI":"10.1136\/jmg.2005.032367","article-title":"Global analysis of uniparental disomy using high density genotyping arrays","volume":"42","author":"Bruce","year":"2005","journal-title":"J Med Genet"},{"key":"10.1053\/j.seminhematol.2011.04.001_bib50","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1086\/431652","article-title":"Segmental duplications and copy-number variation in the human genome","volume":"77","author":"Sharp","year":"2005","journal-title":"Am J Hum Genet"},{"key":"10.1053\/j.seminhematol.2011.04.001_bib51","doi-asserted-by":"crossref","first-page":"1101","DOI":"10.1086\/374385","article-title":"Genome architecture catalyzes nonrecurrent chromosomal rearrangements","volume":"72","author":"Stankiewicz","year":"2003","journal-title":"Am J Hum Genet"},{"key":"10.1053\/j.seminhematol.2011.04.001_bib52","doi-asserted-by":"crossref","first-page":"1809","DOI":"10.1158\/0008-5472.CAN-08-2739","article-title":"DDB1-CUL4 and MLL1 mediate oncogene-induced p16INK4a activation","volume":"69","author":"Kotake","year":"2009","journal-title":"Cancer Res"},{"key":"10.1053\/j.seminhematol.2011.04.001_bib53","doi-asserted-by":"crossref","first-page":"2908","DOI":"10.1101\/gad.1586007","article-title":"Nuclear accumulation of cyclin D1 during S phase inhibits Cul4-dependent Cdt1 proteolysis and triggers p53-dependent DNA rereplication","volume":"21","author":"Aggarwal","year":"2007","journal-title":"Genes Dev"},{"key":"10.1053\/j.seminhematol.2011.04.001_bib54","doi-asserted-by":"crossref","first-page":"2199","DOI":"10.1158\/0008-5472.CAN-04-1526","article-title":"CDK4 and MDM2 gene alterations mainly occur in highly proliferative and aggressive mantle cell lymphomas with wild-type INK4a\/ARF locus","volume":"65","author":"Hernandez","year":"2005","journal-title":"Cancer Res"},{"key":"10.1053\/j.seminhematol.2011.04.001_bib55","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1182\/blood.V99.1.238","article-title":"ATM gene inactivation in mantle cell lymphoma mainly occurs by truncating mutations and missense mutations involving the phosphatidylinositol-3 kinase domain and is associated with increasing numbers of chromosomal imbalances","volume":"99","author":"Camacho","year":"2002","journal-title":"Blood"},{"key":"10.1053\/j.seminhematol.2011.04.001_bib56","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/j.ccr.2006.07.002","article-title":"BRIT1 regulates early DNA damage response, chromosomal integrity, and cancer","volume":"10","author":"Rai","year":"2006","journal-title":"Cancer Cell"},{"key":"10.1053\/j.seminhematol.2011.04.001_bib57","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1182\/blood-2005-05-2091","article-title":"The proteasome inhibitor bortezomib induces apoptosis in mantle-cell lymphoma through generation of ROS and Noxa activation independent of p53 status","volume":"107","author":"Perez-Galan","year":"2006","journal-title":"Blood"},{"key":"10.1053\/j.seminhematol.2011.04.001_bib58","doi-asserted-by":"crossref","first-page":"2849","DOI":"10.1158\/1078-0432.CCR-06-3040","article-title":"Microtubule-associated proteins as targets in cancer chemotherapy","volume":"13","author":"Bhat","year":"2007","journal-title":"Clin Cancer Res"},{"key":"10.1053\/j.seminhematol.2011.04.001_bib59","doi-asserted-by":"crossref","first-page":"1669","DOI":"10.1002\/ijc.22404","article-title":"Expression of centrosome-associated gene products is linked to tetraploidization in mantle cell lymphoma","volume":"120","author":"Neben","year":"2007","journal-title":"Int J Cancer"},{"key":"10.1053\/j.seminhematol.2011.04.001_bib60","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1111\/j.1365-2141.2005.05630.x","article-title":"Gene expression profiling of mantle cell lymphoma cells reveals aberrant expression of genes from the PI3K-AKT, WNT and TGFbeta signalling pathways","volume":"130","author":"Rizzatti","year":"2005","journal-title":"Br J Haematol"},{"key":"10.1053\/j.seminhematol.2011.04.001_bib61","doi-asserted-by":"crossref","first-page":"1668","DOI":"10.1182\/blood-2006-04-015586","article-title":"Constitutive activation of Akt contributes to the pathogenesis and survival of mantle cell lymphoma","volume":"108","author":"Rudelius","year":"2006","journal-title":"Blood"},{"key":"10.1053\/j.seminhematol.2011.04.001_bib62","doi-asserted-by":"crossref","first-page":"5142","DOI":"10.1182\/blood-2007-07-103481","article-title":"Distinct functional significance of Akt and mTOR constitutive activation in mantle cell lymphoma","volume":"111","author":"Dal","year":"2008","journal-title":"Blood"},{"key":"10.1053\/j.seminhematol.2011.04.001_bib63","doi-asserted-by":"crossref","first-page":"2171","DOI":"10.2353\/ajpath.2006.051078","article-title":"Activation of mammalian target of rapamycin signaling promotes cell cycle progression and protects cells from apoptosis in mantle cell lymphoma","volume":"169","author":"Peponi","year":"2006","journal-title":"Am J Pathol"},{"key":"10.1053\/j.seminhematol.2011.04.001_bib64","doi-asserted-by":"crossref","first-page":"542","DOI":"10.1182\/blood-2010-02-269514","article-title":"Bortezomib resistance in mantle cell lymphoma is associated with plasmacytic differentiation","volume":"117","author":"Perez-Galan","year":"2010","journal-title":"Blood"},{"key":"10.1053\/j.seminhematol.2011.04.001_bib65","doi-asserted-by":"crossref","first-page":"3822","DOI":"10.1200\/JCO.2008.20.7977","article-title":"Phase III study to evaluate temsirolimus compared with investigator's choice therapy for the treatment of relapsed or refractory mantle cell lymphoma","volume":"27","author":"Hess","year":"2009","journal-title":"J Clin Oncol"},{"key":"10.1053\/j.seminhematol.2011.04.001_bib66","doi-asserted-by":"crossref","first-page":"5171","DOI":"10.1182\/blood-2008-02-139212","article-title":"Constitutive activation of the Wnt canonical pathway in mantle cell lymphoma","volume":"112","author":"Gelebart","year":"2008","journal-title":"Blood"},{"key":"10.1053\/j.seminhematol.2011.04.001_bib67","doi-asserted-by":"crossref","first-page":"1617","DOI":"10.1182\/blood-2007-02-068791","article-title":"Functionally associated targets in mantle cell lymphoma as defined by DNA microarrays and RNA interference","volume":"111","author":"Ortega-Paino","year":"2008","journal-title":"Blood"},{"key":"10.1053\/j.seminhematol.2011.04.001_bib68","doi-asserted-by":"crossref","first-page":"2630","DOI":"10.1182\/blood-2009-09-243147","article-title":"microRNA expression profile and identification of miR-29 as a prognostic marker and pathogenetic factor by targeting CDK6 in mantle cell lymphoma","volume":"115","author":"Zhao","year":"2010","journal-title":"Blood"},{"key":"10.1053\/j.seminhematol.2011.04.001_bib69","doi-asserted-by":"crossref","first-page":"1335","DOI":"10.1038\/leu.2010.91","article-title":"Mantle cell lymphoma: transcriptional regulation by microRNAs","volume":"24","author":"Di","year":"2010","journal-title":"Leukemia"},{"key":"10.1053\/j.seminhematol.2011.04.001_bib70","doi-asserted-by":"crossref","first-page":"2806","DOI":"10.1101\/gad.1872909","article-title":"Genetic dissection of the miR-17\u223c92 cluster of microRNAs in Myc-induced B-cell lymphomas","volume":"23","author":"Mu","year":"2009","journal-title":"Genes Dev"},{"key":"10.1053\/j.seminhematol.2011.04.001_bib71","doi-asserted-by":"crossref","first-page":"R127.1","DOI":"10.1186\/gb-2008-9-8-r127","article-title":"The miR-17-5p microRNA is a key regulator of the G1\/S phase cell cycle transition","volume":"9","author":"Cloonan","year":"2008","journal-title":"Genome Biol"},{"key":"10.1053\/j.seminhematol.2011.04.001_bib72","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1034\/j.1600-0609.2002.00551.x","article-title":"The splenic form of mantle cell lymphoma","volume":"68","author":"Angelopoulou","year":"2002","journal-title":"Eur J Haematol"},{"key":"10.1053\/j.seminhematol.2011.04.001_bib73","doi-asserted-by":"crossref","first-page":"1209","DOI":"10.1200\/JCO.2008.19.6121","article-title":"Outcome of deferred initial therapy in mantle-cell lymphoma","volume":"27","author":"Martin","year":"2009","journal-title":"J Clin Oncol"},{"key":"10.1053\/j.seminhematol.2011.04.001_bib74","doi-asserted-by":"crossref","first-page":"e189","DOI":"10.1200\/JCO.2009.23.9731","article-title":"Time to treatment does not influence overall survival in newly diagnosed mantle-cell lymphoma","volume":"27","author":"Eve","year":"2009","journal-title":"J Clin Oncol"},{"key":"10.1053\/j.seminhematol.2011.04.001_bib75","doi-asserted-by":"crossref","first-page":"1408","DOI":"10.1158\/0008-5472.CAN-09-3419","article-title":"Genomic and gene expression profiling defines indolent forms of mantle cell lymphoma","volume":"70","author":"Fernandez","year":"2010","journal-title":"Cancer Res"},{"key":"10.1053\/j.seminhematol.2011.04.001_bib76","doi-asserted-by":"crossref","first-page":"899","DOI":"10.1038\/nrc2271","article-title":"Roles of HMGA proteins in cancer","volume":"7","author":"Fusco","year":"2007","journal-title":"Nat Rev Cancer"}],"container-title":["Seminars in Hematology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0037196311000461?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0037196311000461?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,22]],"date-time":"2025-09-22T06:20:29Z","timestamp":1758522029000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0037196311000461"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,7]]},"references-count":76,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2011,7]]}},"alternative-id":["S0037196311000461"],"URL":"https:\/\/doi.org\/10.1053\/j.seminhematol.2011.04.001","relation":{},"ISSN":["0037-1963"],"issn-type":[{"value":"0037-1963","type":"print"}],"subject":[],"published":{"date-parts":[[2011,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Molecular Pathogenesis of Mantle Cell Lymphoma: New Perspectives and Challenges With Clinical Implications","name":"articletitle","label":"Article Title"},{"value":"Seminars in Hematology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1053\/j.seminhematol.2011.04.001","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2011 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}